Table 3 The results of primary and secondary patency rates for different lesions in diabetes group
| Â | Â | 6 months | 12 months | 24 months | 36 months |
|---|---|---|---|---|---|
iliac lesions (n = 26) | primary patency rate | 100% | 87.5% ± 6.8% | 82.6% ± 7.9% | 75.1% ± 10.2% |
|  | secondary patency rate | 100% | 95.8% ± 4.1% | 90.8% ± 6.2% | 82.5% ± 9.7% |
femoral | primary patency rate | 88.2% ± 4.5% | 73.2% ± 6.4% | 67.7% ± 7% | 58.6% ± 8.6% |
lesions (n = 51) | secondary patency rate | 94.1% ± 3.3% | 89.8% ± 4.3% | 84.5% ± 5.5% | 73.2% ± 7.8% |
popliteal | primary patency rate | 78.9% ± 9.4% | 42.1% ± 11.3% | 42.1% ± 11.3% | 42.1% ± 11.3% |
lesions (n = 19) | secondary patency rate | 84.2% ± 8.4% | 73.7% ± 10.1% | 62.7% ± 11.2% | 55.8% ± 11.9% |
tibial | primary patency rate | 75.0% ± 10.8% | 53.8% ± 12.9% | 30.8% ± 12.5% | 30.8% ± 12.5% |
lesions (n = 16) | secondary patency rate | 87.5% ± 8.3% | 67.3% ± 12% | 43.6% ± 13.6% | 43.6% ± 13.6% |